You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

You are here

MKSAP 19 "Quiz Me!" Question

Test your medical knowledge each month with questions from The Medical Knowledge Self-Assessment Program® (MKSAP).

MKSAP 19

For over 50 years, the Medical Knowledge Self-Assessment Program (MKSAP) has been the most trusted resource in continuous learning for internal medicine physicians and residents. The tradition continues with MKSAP 19.

MKSAP 19, to be released in early 2022, is available in several flexible formats, allowing you to choose the format that best fits your lifestyle. Each format includes 12 syllabus sections and 1,200 associated deep-learning self-assessment questions.

Learn about the new features in MKSAP 19, as well as pricing and release dates.

MKSAP 19 Q&A

A 26-year-old woman undergoes consultation to update her vaccinations. She is an elementary school teacher. Medical history is significant for well-controlled HIV diagnosed 6 years ago. Medications are tenofovir alafenamide, emtricitabine, and dolutegravir.

The physical examination is normal.

Her CD4 cell count is 520/µL and has been stable for several years. HIV viral load is undetectable.

Which of the following vaccines is contraindicated in this patient?

A: Human papillomavirus
B: Inactivated influenza
C: Measles-mumps-rubella
D: Varicella
E: No contraindications exist

Answer and Critique

Back to the March 2022 issue of ACP IMpact